Path: ...!2.eu.feeder.erje.net!feeder.erje.net!proxad.net!feeder1-2.proxad.net!usenet-fr.net!pasdenom.info!from-devjntp
Message-ID: <VsTWp8MeJkzYHqe2oLpA-pZM7VA@jntp>
JNTP-Route: news2.nemoweb.net
JNTP-DataType: Article
Subject: Preprints et publications (Etait: Re: La formule 2023-24 du vaccin offrait 
 une faible protection)
References: <zkqYN.30908$YIMb.12788@fx15.ams4> <v0thpc$36pbm$1@dont-email.me> <v0trr6$393vf$1@dont-email.me>
 <jgu43jljht3rura9ovc21udemic3vihe3v@news.usenet.ovh> <v0vpj1$3puci$1@dont-email.me>
 <7u183j5o10ruj3ficpq5uoki5cje700v81@news.usenet.ovh> <KX0ZN.15729$TfT8.144@fx09.ams4> <v12fti$ghcs$1@dont-email.me>
 <v12quc$j1a6$1@dont-email.me>
Newsgroups: fr.bio.medecine
JNTP-HashClient: goU7GDkT4TQ9r30X855xO2Fd8cM
JNTP-ThreadID: zkqYN.30908$YIMb.12788@fx15.ams4
JNTP-Uri: http://news2.nemoweb.net/?DataID=VsTWp8MeJkzYHqe2oLpA-pZM7VA@jntp
Supersedes: <2rv6mzP0djhQGkN8Nruyoz6SMBo@jntp>
User-Agent: Nemo/0.999a
JNTP-OriginServer: news2.nemoweb.net
Date: Sat, 04 May 24 11:20:55 +0000
Organization: Nemoweb
JNTP-Browser: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:125.0) Gecko/20100101 Firefox/125.0
Injection-Info: news2.nemoweb.net; posting-host="48db87d9176ce6969124ceb9d6b05e62333c6c22"; logging-data="2024-05-04T11:20:55Z/8842947"; posting-account="2@news2.nemoweb.net"; mail-complaints-to="julien.arlandis@gmail.com"
JNTP-ProtocolVersion: 0.21.1
JNTP-Server: PhpNemoServer/0.94.5
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
X-JNTP-JsonNewsGateway: 0.96
From: Duzz' <jsuis@jreste.invalid>
Bytes: 2100
Lines: 11

Le 03/05/2024 à 16:05, bruno a écrit :
> 
> je serais curieux de savoir quelle est la proportion de prépublications 
> qui aboutissent à un "vraie" publication.

Un article qui évalue cette proportion à 10,6% :
<https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777629>

« Among *8941* preprints posted on medRxiv, *944* had been subsequently 
published in a peer-reviewed journal as of our search date. »